Specialty Drug Spending Continues to Rise, Driven by Higher Utilization

Per-member per-year (PMPY) specialty drug spending rose 13.6% from 2018 to 2019, according to Pharmaceutical Strategies Group’s annual report, which analyzed 45 million pharmacy claims and 54 million medical claims. Contributing to the growth was a 10.3% increase in utilization and a 3.3% rise in costs per claim. Specialty drug spending under the pharmacy benefit saw the largest increase, driven by 19.6% higher utilization of such therapies. In terms of overall cost, inflammatory disorders ranked No. 1 among all drug categories, followed by oncology and multiple sclerosis.

SOURCE: “State of Specialty Spend and Trend Report,” Pharmaceutical Strategies Group, October 2020. Visit https://bwnews.pr/2HUxyiJ.

Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

businessmen-pointing-at-a-cellphone
January 19

Industry Will Continue to See 340B, Patient-Paid Prescription Impact as IRA Looms

Read More
a-doctor-giving-injection
January 19

FDA Approves Gilead’s First-in-Class HIV Drug Sunlenca

Read More
two-business-people-typing-on-a-tablet
January 19

New Organization Will Focus on Medical Benefit Drugs

Read More

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today